DEVICE FOR THE TREATMENT OF STRESS URINARY INCONTINENCE
20240000446 ยท 2024-01-04
Inventors
Cpc classification
A61B2017/06009
HUMAN NECESSITIES
A61B2017/06052
HUMAN NECESSITIES
A61B2017/00455
HUMAN NECESSITIES
A61B17/0401
HUMAN NECESSITIES
A61B90/37
HUMAN NECESSITIES
International classification
A61B17/04
HUMAN NECESSITIES
A61B17/06
HUMAN NECESSITIES
Abstract
A needle (16) for deploying a suture is provided. The needle (16) has a feeding end (11) with an aperture (19) for receiving the suture and a pointed end (3) for creating an incision. The needle (16) extends between the feeding end (11) and the pointed end (3). The needle (16) also has a second aperture (18) and an interior channel (5) extending between the first aperture (19) and the second aperture (18) for transporting the suture from the first aperture (19) to the second aperture (18). A kit for deploying sutures includes at least one suture, at least one needle (16) and at least one pusher (12). The pusher (12) pushes the suture through the interior channel (5) of the needle (16) and out of the second aperture (18).
Claims
1. A needle for deploying a suture, the needle comprising: a feeding end comprising a first aperture for receiving the suture; a pointed end for creating an incision, wherein the needle extends between the feeding end and the pointed end; a second aperture proximal to and spaced from the pointed end; and an interior channel extending between the first aperture and the second aperture for transporting the suture from the first aperture to the second aperture.
2. The needle as claimed in claim 1, wherein the pointed end comprises a bevel.
3. The needle as claimed in claim 1, wherein the second aperture extends through a wall of the needle.
4. (canceled)
5. The needle as claimed in claim 1, wherein the needle comprises markings indicating the side of the needle in which the second aperture is formed.
6. The needle as claimed in claim 1, wherein the particular distance is based on the thickness of a target human or animal tissue and/or the angle at which the end of the suture exits from the second aperture into the target tissue.
7. The needle as claimed in claim 1, wherein a portion of the needle between the pointed end and the second aperture is closed.
8. The needle as claimed in claim 1, wherein a portion of the needle between the pointed end and the second aperture is solid.
9. The needle as claimed in claim 1, wherein the interior channel comprises a deflection surface arranged to deflect a suture toward the second aperture when the suture is incident on the deflection surface.
10. The needle as claimed in claim 9, wherein the deflection surface is on a side of the second aperture proximal to the pointed end of the needle.
11. The needle as claimed in claim 9, wherein the deflection surface comprises one side of the wall of the interior channel, which optionally forms a curve toward an edge of the second aperture proximal to the pointed end of the needle.
12. The needle as claimed in claim 1, wherein the needle comprises a material that is visible through fluoroscopic imaging and/or CT imaging.
13. (canceled)
14. The needle as claimed in claim 1, wherein the needle is arranged to receive a pusher for pushing the suture through the interior channel of the needle and out of the second aperture.
15. A kit for deploying sutures, comprising: at least one suture; at least one needle according to claim 1; and at least one pusher, arranged to push the suture through the interior channel of the needle and out of the second aperture.
16. The kit as claimed in claim 15, wherein the at least one suture is a T-bar suture.
17. The kit as claimed in claim 16, wherein each suture comprises a footplate portion and a thread portion.
18. (canceled)
19. The kit as claimed in claim 15, comprising a member for inserting into an orifice of the human or animal body, wherein the member is arranged to support the pointed end of the needle in a target human or animal tissue and wherein the member is cylindrical with a tapered end.
20. (canceled)
21. The kit as claimed in claim 15, wherein the suture comprises a free end and the kit comprises an anchoring device for securing the free end of each suture under tension at an anchoring point.
22. The kit as claimed in claim 15, further comprising a tunnelling device for pulling the thread portion or free end of each suture through tissue to an anchoring point.
23-25. (canceled)
26. A method for the treatment of stress urinary incontinence, the method comprising: inserting the needle of claim 1, into a female human or animal body; advancing the needle until the pointed end reaches a periurethral anterior vaginal wall tissue; transporting the suture through the interior channel of the needle until the end of the suture exits the needle through the second aperture and the suture is retained in the periurethral anterior vaginal wall tissue; removing the needle from the female human or animal body; and securing the suture, under tension such that a pubourethral ligament is reinforced.
27. A method for the treatment of stress urinary incontinence, the method comprising: transporting a T-bar suture into a periurethral anterior vaginal wall tissue of a female human or animal body such that the T-bar suture is retained in the periurethral anterior vaginal wall tissue; and securing the T-bar suture, under tension such that a pubourethral ligament is reinforced.
Description
[0089] One or more non-limiting examples will now be described, by way of example only, and with reference to the accompanying figures in which:
[0090]
[0091]
[0092]
[0093]
[0094]
[0095]
[0096]
[0097]
[0098]
[0099]
[0100]
[0101]
[0102]
[0103] In
[0104] Although the needle 16 is suitable for deploying any type of suitable suture, one preferred type of suture 7 is shown in
[0105] In
[0106] In the embodiment shown in
[0107] As shown in
[0108]
[0109]
[0110] The suture deployment apparatus 2 comprises the needle 16, a T-bar suture 7 and a pushing rod 12. The deployment takes place once the needle 16 has been inserted, such that the side-hole 19 is situated within the target tissue of a human or animal body, as will be described in more detail below.
[0111] In operation, first the T-bar suture 7 is placed in the interior channel 5 of the needle 16. The flexibility of the thread 8 allows the suture 7 to bend so that the longitudinal axis of the footplate 6 aligns with the longitudinal axis of the needle 16. The suture 7 is inserted into the first aperture 19 of the needle 16, followed by the pusher 12 which is then gradually fed through the interior channel 5 of the needle 16.
[0112] As can be seen in
[0113] As the pusher 12 pushes the suture 7 through the interior channel 5, the footplate 6 approaches the curved surface 14 which directs the footplate 6 out of the second aperture (side-hole) 18.
[0114] The step of the process where the footplate 6 of the T-bar suture 7 exits from the side-hole 18 is shown in
[0115] The pushing rod 12 is pushed through the needle 16 such that the tip of the pushing rod 12 (distal from the handling/feeding end 10) reaches the side-hole 18. The T-bar suture 7 is shown exiting the side-hole 18 at an angle to the longitudinal axis of the needle 16. The curved surface 14 results in smooth delivery of the suture 7, reducing the likelihood of the suture 7 snagging or stopping when the suture 7 is exiting the aperture 18.
[0116] Having the second aperture 18 at the side of the needle 16, in combination the curved surface 14, causes the T-bar suture 7 to be deployed into the soft tissue substantially perpendicular to the longitudinal axis of the needle 16. This is advantageous as the footplate 6 can be anchored better into the target tissue when the footplate 6 is angled such that the longitudinal axis of the footplate 6 is approximately perpendicular to the direction the thread 8 will be pulled. When the suture 7 is secured under tension, and the thread 8 is pulled, it is less likely to move around in or slip through the target tissue than other types of suture.
[0117] In
[0118] The apparatus 2 could be used for a variety of procedures that may involve depositing a suture 7 into the soft tissue of an animal or human body. However, in a preferred embodiment, the apparatus 2 is used for the treatment of stress urinary incontinence in females. The procedure for treating stress urinary incontinence will 35 be described with reference to
[0119] The procedure described is similar to laparoscopic colposuspension, however, the apparatus 2 enables the treatment to be completed more efficiently, using only local anaesthetic. The procedure described may be more minimally invasive and less morbid in comparison with existing treatments for SUI. It is envisaged that the procedure described will make treatment easier to perform such that a larger number of practitioners (including radiologists and surgeons), not essentially trained in laparoscopic surgeries, are able to perform minimally invasive SUI treatments.
[0120]
[0121] In
[0122]
[0123] Before the needle is inserted, a 6-8 French (1 French= mm) urinary catheter may be used to fill the bladder with a dilute contrast agent (then a concentrated contrast agent (3 ml)) to show the catheter tubing better under fluoroscopy. The practitioner may then manipulate the image intensifier with appropriate craniocaudal, right anterior oblique (RAO) and/or left anterior oblique (LAO) tilt, until a clear path can be seen (not overlaid by bony or vascular structures) and the catheter in the mid-urethra can be seen on a viewing screen. The practitioner then centres the display and may also use laser crosshairs to mark the incision/puncture area. The local anaesthetic would then be infiltrated in-line with the laser crosshairs with a spinal needle down to the vaginal wall 22 to the ipsilateral side of the urethra (not pictured). Ultrasound imaging may also be used during the procedure to ensure that important soft tissue structures such as blood vessels and nerves are not in line with the path of the needle.
[0124] To insert the needle 16 into the position shown in
[0125] The needle 16 may pass through the obturator foramen to reach this position or via other approaches mentioned above. Digital vaginal examination may be performed synchronously to ensure that the vaginal wall is not traversed. The needle 16 should pass close to the periosteum where there is strong ligamentous tissue for suture 7 fixation. The target tissue (where the sutures are to be placed), in this procedure, is the periurethral anterior vaginal wall tissue.
[0126]
[0127] The suture 7 is pushed down through the needle 16, with a pushing rod 12 pushing the suture 7 through the interior channel 5 of the needle 16 until the footplate 6 of the suture 7 exits the second aperture 18 and is retained in the periurethral anterior vaginal wall tissue, as illustrated in
[0128] The needle 16 and pusher 12 are then removed, leaving the suture 7 in position in the tissue, and the process is repeated on the other side, with another suture 7 deployed in the vaginal wall 22, entering through the groin again but on the other side of the body.
[0129] Turning back to
[0130]
[0131] In
[0132] An alternative approach of the needle would be inferior to the pubic bone (not pictured). This approach may require a shorter needle inserted at a narrower angle and helps to reduce the risk of injury to the femoral vessels/nerves.
[0133] In
[0134]
[0135] In
[0136] The same incision that was made for the needle is used for the crimps. In this case, tunnelling to the midline is not necessary.
[0137] An absorbable material may be used for the footplate 6 of the suture. The formation of natural scar tissue related to suture absorption would then cause the urethra to be supported, having lasting positive effects after the footplate 6 is absorbed. To achieve this, the footplate 6 could be made from a bio-absorbable polymere.g. a 50:50 blend of lactide and glycolide polymers. Additionally, the crimp 26, 28 may be made from a bio-absorbable material. The treatment may involve a completely absorbable system, such that the SUI treatment does not leave permanent synthetic material behind in the body. If the suture 7 is entirely absorbable, scar tissue would form along the whole suture tract and effectively replace the whole system (T-bar, suture, crimp).
[0138] While the invention has been described in detail in connection with only a limited number of embodiments, it should be readily understood that the invention is not limited to such disclosed embodiments. Rather, the invention can be modified to incorporate any number of variations, alterations, substitutions or equivalent arrangements not heretofore described, but which are commensurate with the scope of the invention. Additionally, while various embodiments of the invention have been described, it is to be understood that aspects of the invention may include only some of the described embodiments. Accordingly, the invention is not to be seen as limited by the foregoing description, but is only limited by the scope of the appended claims.